-
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 20-1257V (not to be published) ANITA BRIANT, Chief Special Master Corcoran Petitioner, v. Filed: August 11, 2022 SECRETARY OF HEALTH AND Special Processing Unit (SPU); HUMAN SERVICES, Attorney’s Fees and Costs Respondent. Brittany Rose Wolf-Freedman, Gainsburgh, Benjamin, David, Meunier, & Warshauer, LLC, New Orleans, LA, for Petitioner. Alexis B. Babcock, U.S. Department of Justice, Washington, DC, for Respondent. DECISION ON ATTORNEY’S FEES AND COSTS 1 On September 24, 2020, Anita Briant filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq. 2 (the “Vaccine Act”). Petitioner alleges that she suffered a shoulder injury related to vaccine administration as a result of an influenza vaccine administered to her on September 3, 2019. (Petition at 1). On February 17, 2022, a decision was issued awarding compensation to Petitioner based on the Respondent’s proffer. (ECF No. 29). 1 Because this unpublished Decision contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E- Government Act of 2002.
44 U.S.C. § 3501note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986,
Pub. L. No. 99-660, 100Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Petitioner has now filed a motion for attorney’s fees and costs, dated May 16, 2022 (ECF No. 39), requesting a total award of $20,713.27 (representing $19,699.65 in fees and $1,013.62 in costs). In accordance with General Order No. 9, Petitioner filed a signed statement indicating that she incurred no out-of-pocket expenses. (ECF No. 39-4). Respondent reacted to the motion on May 17, 2022, indicating that he is satisfied that the statutory requirements for an award of attorney’s fees and costs are met in this case, but deferring resolution of the amount to be awarded at the Court’s discretion. (ECF No. 41). On May 17, 2022, Petitioner filed a reply requesting “a reasonable award for attorneys’ fees and costs based upon the documents Petitioner submitted in her original Application”. (ECF No. 42). A scheduling order was filed on July 12, 2022, requesting Petitioner file supporting documentation in her request for attorney costs. (ECF No. 44). Petitioner filed a supplemental motion for attorney’s fees and costs providing the requested documentation. (ECF No. 45). Respondent did not file a response to Petitioner’s supplemental motion. I have reviewed the billing records submitted with Petitioner’s request. In my experience, the request appears reasonable, and I find no cause to reduce the requested hours or rates. The Vaccine Act permits an award of reasonable attorney’s fees and costs. Section 15(e). Accordingly, I hereby GRANT Petitioner’s Motion for attorney’s fees and costs. I award a total of $20,713.27 (representing $19,699.65 in fees and $1,013.62 in costs) as a lump sum in the form of a check jointly payable to Petitioner and Petitioner’s counsel. In the absence of a timely-filed motion for review (see Appendix B to the Rules of the Court), the Clerk shall enter judgment in accordance with this decision. 3 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by filing a joint notice renouncing their right to seek review. 2
Document Info
Docket Number: 20-1257
Judges: Brian H. Corcoran
Filed Date: 9/12/2022
Precedential Status: Non-Precedential
Modified Date: 9/12/2022